Graves Kurt 4
4 · Seres Therapeutics, Inc. · Filed Apr 11, 2025
Insider Transaction Report
Form 4
Graves Kurt
Director
Transactions
- Award
Stock Option (right to buy)
2025-04-10+100,000→ 100,000 totalExercise: $0.58Exp: 2035-04-09→ Common Stock (100,000 underlying)
Footnotes (1)
- [F1]The option vests in full on the earlier of April 10, 2026 or the day immediately prior to the company's 2026 annual meeting of shareholders.